Acesso livre
Acesso livre

Infectologia

Revisão | Tratamento da síndrome inflamatória multissistêmica (MIS-C) em crianças e adolescentes.

20 Jan, 2022 | 21:27h

Treatment of MIS-C in Children and Adolescents – Current Pediatrics Reports

Ver também: Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations – World Journal of Pediatrics

Conteúdos relacionados:

Review of 4,470 cases of Multisystem Inflammatory Syndrome in Children in the US.

WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19.

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

Perspectiva | Consequências neurológicas pós-agudas da COVID-19: um impacto desigual – “A COVID-19 e suas consequências neurológicas afetaram particularmente as comunidades marginalizadas e, portanto, só poderão ser efetivamente tratadas por meio do avanço na equidade em saúde.”

20 Jan, 2022 | 21:20h

Post-acute neurological consequences of COVID-19: an unequal burden – Nature Medicine

Série de casos de síndrome da trombocitopenia com trombose após vacinação contra Covid-19 nos EUA.

20 Jan, 2022 | 21:18h

Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021 – Annals of Internal Medicine

Editorial: The Epidemiology of Thrombosis With Thrombocytopenia Syndrome: Analogies With Heparin-Induced Thrombocytopenia – Annals of Internal Medicine

Lesões no ombro relacionadas à administração da vacina contra o SARS-CoV-2.

20 Jan, 2022 | 21:10h

Shoulder injury related to SARS-CoV-2 vaccine administration – Canadian Medical Association Journal

Diretriz ACP | Diagnóstico e tratamento da diverticulite colônica aguda de lado esquerdo.

20 Jan, 2022 | 21:09h

Diagnosis and Management of Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

Diretriz relacionada: Colonoscopy for Diagnostic Evaluation and Interventions to Prevent Recurrence After Acute Left-Sided Colonic Diverticulitis: A Clinical Guideline From the American College of Physicians – Annals of Internal Medicine

Revisões sistemáticas relacionadas:

Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine

Evaluation and Management After Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine

Resumo em vídeo: Diagnostic Imaging and Medical Management of Acute Left-Sided Colonic Diverticulitis: A Systematic Review – Annals of Internal Medicine

Comunicado de imprensa: ACP releases two new clinical guidelines on the diagnosis and management of diverticulitis – American College of Physicians

Estudo randomizado por cluster | Banho antisséptico com compressas impregnadas de clorexidina 2% e lavagem com luvas com octenidina 0,08% não foram efetivos na prevenção de infecções de corrente sanguínea associadas a cateter central em pacientes de terapia intensiva.

20 Jan, 2022 | 20:41h

Effect of antiseptic bathing with chlorhexidine or octenidine on central-line associated bloodstream infections in intensive care patients: a cluster-randomised controlled trial – Clinical Microbiology and Infection

OMS recomenda dois novos medicamentos (baricitinibe e sotrovimabe) para tratar COVID-19.

20 Jan, 2022 | 20:20h

Comunicado de imprensa: WHO recommends two new drugs to treat COVID-19 – World Health Organization

Infográfico com recomendações atualizadas: A living WHO guideline on drugs for covid-19 – The BMJ

Comentários:

WHO Recommends Two New COVID-19 Treatments – Cost and Availability Likely Barriers – Health Policy Watch

Expert reaction to WHO recommending two drugs, sotrovimab and baricitinib, to treat patients with COVID-19 – Science Media Centre

 

Comentário no Twitter (fio – clique para saber mais)

 

CDC pede que os norte-americanos usem continuamente máscaras que protejam mais e que estejam bem ajustadas.

20 Jan, 2022 | 20:18h

CDC urges Americans to wear most-protective mask or respirator that fits well and that they’ll wear consistently – CNN

Diretriz CDC: Types of Masks and Respirators – Centers for Disease Control and Prevention

Ver também: CDC encourages more Americans to consider N95 masks – STAT

Ascensão do preprint: quão rápido o compartilhamento de dados durante a pandemia de COVID-19 mudou a ciência para sempre.

20 Jan, 2022 | 20:16h

Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever – Nature Medicine

Internações hospitalares por infecções comuns da infância foram muito reduzidas na Inglaterra durante a pandemia em virtude das medidas de controle para Covid-19.

20 Jan, 2022 | 20:15h

Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study – The BMJ

Editorial: Covid-19 control measures and common paediatric infections – The BMJ

Comunicado de imprensa: Dramatic fall in hospital admissions for child infections during first year of covid-19 pandemic – BMJ

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.